Case Report: Heparin-induced thrombocytopenia during COVID-19 outbreak: the importance of scoring system in differentiating with sepsis-induced coagulopathy

Background: COVID-19 disease is accompanied by derangement of coagulation with a risk of fatal thromboembolic formation. COVID-19 patients are among those indicative for heparin treatment. Increased heparin administration among COVID-19 patients increased heparin induced-thrombocytopenia's risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardhani, Louisa Fadjri Kusuma, Dewi, Ivana Purnama, Suwanto, Denny, Ambari, Ade Meidian, Ardiana, Meity
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356265/
https://www.ncbi.nlm.nih.gov/pubmed/34394916
http://dx.doi.org/10.12688/f1000research.52425.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356265/
https://www.ncbi.nlm.nih.gov/pubmed/34394916
http://dx.doi.org/10.12688/f1000research.52425.2

Ejemplares similares